1
Tremblay, F, Lavigne, C, Jacques, H, et al. (2001) Defective insulin-induced GLUT4 translocation in skeletal muscle of high fat-fed rats is associated with alterations in both Akt/protein kinase B and atypical protein kinase C activities. Diabetes
50, 1901–1910.
2
Brons, C, Jensen, CB, Storgaard, H, et al. (2009) Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men. J Physiol
587, 2287–2297.
3
Defronzso, RA (2004) Dysfunctional fat cells, lipotoxicity and type 2 diabetes. Int J Clin Pract
58, 9–21.
4
Cani, PD, Amar, J, Iglesias, MA, et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes
56, 1761–1772.
5
Cani, PD, Bibiloni, R, Knauf, C, et al. (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes
57, 1470–1481.
6
Cani, PD, Possemiers, S, van de Wiele, T, et al. (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut
58, 1091–1103.
7
Serino, M, Luche, E, Gres, S, et al. (2012) Metabolic adaptations to a high-fat diet is associated with a change in the gut microbiota. Gut
61, 543–553.
8
Larsen, N, Vogensen, FK, van den Berg, FWJ, et al. (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PloS ONE
5, e9085.
9
Amar, J, Burcelin, R, Ruidavets, JB, et al. (2008) Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr
87, 1219–1223.
10
Pendyala, S, Walker, JM & Holt, PR (2012) A high-fat diet is associated with endotoxemia that originates in the gut. Gastroenterology
142, 1100–1101.
11
Naito, E, Yoshida, Y, Makino, K, et al. (2011) Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet-induced obesity mice. J App Microbiol
110, 650–657.
12
Ejtahed, HS, Mohtadi-Nia, J, Homayouni-Rad, A, et al. (2012) Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition
28, 539–543.
13
Spanhaak, S, Havenaar, R & Schaafsma, G (1998) The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr
52, 899–907.
14
Matsumoto, K, Takada, T, Shimizu, K, et al. (2010) Effects of a probiotic fermented milk beverage containing Lactobacillus casei strain Shirota on defecation frequency, intestinal microbiota, and the intestinal environment of healthy individuals with soft stools. J Biosci Bioeng
110, 547–552.
15
Nagata, S, Asahara, T, Ohta, T, et al. (2011) Effect of the continuous intake of probiotic-fermented milk containing Lactobacillus casei strain Shirota on fever in a mass outbreak of norovirus gastroenteritis and the faecal microflora in a health service facility for the aged. Br J Nutr
106, 549–556.
16
Matsuda, M & DeFronzo, RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care
22, 1462–1470.
17
Kraegen, EW, Storlien, LH, Jenkins, AB, et al. (1989) Chronic exercise compensates for insulin resistance induced by a high-fat diet in rats. Am J Physiol Endocrinol Metab
256, E242–E249.
18
Kim, C, Youg, JH, Park, J, et al. (2000) Effects of high-fat diet and exercise training on intracellular glucose metabolism in rats. Am J Physiol Endocrinol Metab
278, E977–E984.
19
Lessard, SJ, Rivas, DA, Chen, K, et al. (2007) Tissue-specific effects of rosiglitazone and exercise in the treatment of lipid-induced insulin resistance. Diabetes
56, 1856–1864.
20
Todd, MK, Watt, MJ, Le, J, et al. (2007) Thiazolidinediones enhanced skeletal muscle triacylglycerol synthesis while protecting against fatty acid-induced inflammation and insulin resistance. Am J Physiol Endocrinol Metab
292, E485–E493.
21
Barclay, JL, Shostak, A, Leliavski, A, et al. (2013) High fat diet-induced hyperinsulinemia and tissue-specific insulin resistance in Cry deficient mice. Am J Physiol Endocrinol Metab
304, E1053–E1063.
22
Bielohuby, M, Sisley, S, Sandoval, D, et al. (2013) Impaired glucose tolerance in rats fed low-carbohydrate, high-fat diets. Am J Physiol Endocrinol Metab
305, E1059–E1070.
23
Wiedemann, MSF, Wueest, S, Item, F, et al. (2013) Adipose tissue inflammation contributes to short-term high-fat diet-induced hepatic insulin resistance. Am J Physiol Endocrinol Metab
305, E388–E395.
24
Adochio, RL, Leitner, JW, Gray, K, et al. (2009) Early responses of insulin signalling to high-carbohydrate and high-fat overfeeding. Nutr Metab
6, 37.
25
Cornford, AS, Hinko, A, Nelson, RK, et al. (2013) Rapid development of systemic insulin resistance with overeating is not accompanied by robust changes in skeletal muscle glucose and lipid metabolism. Appl Physiol Nutr Metab
38, 512–519.
26
Yu, C, Chen, Y, Zong, H, et al. (2002) Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem
277, 50230–50236.
27
Kleemann, R, van Erk, M, Verschuren, L, et al. (2010) Time-resolved and tissue-specific systems analysis of the pathogenesis of insulin resistance. PloS ONE
5, e8817.
28
Samuel, VT & Shulman, GI (2012) Mechanisms for insulin resistance: common threads and missing links. Cell
148, 852–871.
29
Pussinen, PJ, Havulinna, AS, Lehto, M, et al. (2011) Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care
34, 392–397.
30
Harte, AL, Varma, MC, Tripathi, G, et al. (2012) High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects. Diabetes Care
35, 375–382.
31
Mehta, NN, McGillicuddy, FC, Anderson, PD, et al. (2010) Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes
59, 172–181.
32
Hotamisligil, G, Peraldi, P, Budavari, A, et al. (1996) IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α and obesity-induced insulin resistance. Science
271, 665–668.
33
Brun, P, Castagliuolo, I, Di Leo, V, et al. (2007) Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol
292, G518–G525.
34
Matsuzaki, T, Yamazaki, R, Hashimoto, S, et al. (1997) Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-Ay mice. Endocr J
44, 357–365.
35
Matsuzaki, T, Nagata, Y, Kado, S, et al. (1997) Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei
. APMIS
105, 643–649.
36
Harisa, GI, Taha, EI, Khalil, AF, et al. (2009) Oral administration of Lactobacillus acidophilus restores nitric oxide level in diabetic rats. Aust J Basic Appl Sci
3, 2963–2969.
37
Tanida, M, Imanishi, K, Akashi, H, et al. (2014) Injection of Lactobacillus casei strain Shirota affects autonomic nerve activities in a tissue-specific manner, and regulates glucose and lipid metabolism in rats. J Diabetes Investig
5, 153–161.
38
Triplot, NJ, Leber, B, Blattl, D, et al. (2012) Effect of supplementation with Lactobacillus casei Shirota on insulin sensitivity, β-cell function, and markers of endothelial function and inflammation in subjects with the metabolic syndrome – a pilot study. J Dairy Sci
96, 89–95.
39
Wulan, SN, Westerterp, KR & Plasqui, G (2014) Metabolic profile before and after short-term overfeeding with a high-fat diet: a comparison between South Asian and white men. Br J Nutr
111, 1853–1861.
40
Hudgins, LC, Hellerstein, M, Seidman, C, et al. (1996) Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet. J Clin Invest
97, 2081–2091.
41
Retzlaff, BM, Walden, CE, Dowdy, AA, et al. (1995) Changes in plasma triacylglycerol concentrations among free-living hyperlipidemic men adopting different carbohydrate intakes over 2 years: the Dietary Alternatives Study. Am J Clin Nutr
62, 988–995.
42
Hellerstein, MK (2002) Carbohydrate-induced hypertriglyceridemia: modifying factors and implications for cardiovascular risk. Curr Opin Lipidol
13, 33–40.
